Decrease or loss of the sodium iodide (Na+/I-) symporter (NIS) activity influences the suitability of using radioiodine to detect and treat metastatic thyroid tissues. In previous studies, the presence of the NIS transcript, albeit at lower expression levels, has been shown in most thyroid differentiated carcinomas. In this study we searched for point mutations or other genetic alterations that may be responsible for an altered function of the NIS protein in tumors that still express NIS transcripts. Tumoral cDNAs derived from seven differentiated thyroid carcinomas (DTC), five papillary and two follicular, were analyzed by direct sequencing after polymerase chain reaction (PCR) amplification of the structural gene of the Na+/I- symporter. Neither mutations nor other genetic abnormalities were detected in any tumor sample examined. The data indicate that mutations or other genetic alterations of the NIS structural gene are not a major cause of the reduced iodide uptake in DTC.

Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas / Diego, Russo; Diana, Manole; Franco, Arturi; Horacio G., Suarez; Martin, Schlumberger; Filetti, Sebastiano; Michael, Derwahl. - In: THYROID. - ISSN 1050-7256. - 11:1(2001), pp. 37-39. [10.1089/10507250150500649]

Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas

FILETTI, SEBASTIANO;
2001

Abstract

Decrease or loss of the sodium iodide (Na+/I-) symporter (NIS) activity influences the suitability of using radioiodine to detect and treat metastatic thyroid tissues. In previous studies, the presence of the NIS transcript, albeit at lower expression levels, has been shown in most thyroid differentiated carcinomas. In this study we searched for point mutations or other genetic alterations that may be responsible for an altered function of the NIS protein in tumors that still express NIS transcripts. Tumoral cDNAs derived from seven differentiated thyroid carcinomas (DTC), five papillary and two follicular, were analyzed by direct sequencing after polymerase chain reaction (PCR) amplification of the structural gene of the Na+/I- symporter. Neither mutations nor other genetic abnormalities were detected in any tumor sample examined. The data indicate that mutations or other genetic alterations of the NIS structural gene are not a major cause of the reduced iodide uptake in DTC.
01 Pubblicazione su rivista::01a Articolo in rivista
Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas / Diego, Russo; Diana, Manole; Franco, Arturi; Horacio G., Suarez; Martin, Schlumberger; Filetti, Sebastiano; Michael, Derwahl. - In: THYROID. - ISSN 1050-7256. - 11:1(2001), pp. 37-39. [10.1089/10507250150500649]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/92726
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 25
social impact